James Ryan
Cardiovascular Disease · Hermitage, PANPI 1659318699
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 393 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,542 and has fallen 98.5% since, to $24 in 2023.
Across 393 payments — averaging $13.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$886
- Amarin Pharma, Inc.$686
- Novartis$578
- Amgen$483
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$483
- AstraZeneca$367
- plus $2K from 19 others
What the payments were for
- Food & beverage$5,10599%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 106 | $886 |
| Amarin Pharma, Inc. | 39 | $686 |
| Novartis | 54 | $578 |
| Amgen | 28 | $483 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 38 | $483 |
| AstraZeneca | 22 | $367 |
| Boehringer Ingelheim | 29 | $344 |
| Sanofi-aventis U.S. LLC | 15 | $210 |
| Pfizer | 9 | $161 |
| Kowa Pharmaceuticals America, Inc. | 8 | $123 |
| Merck | 7 | $115 |
| Astellas Pharma US Inc | 1 | $105 |
| Abbott | 5 | $98 |
| Boston Scientific | 4 | $93 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| Actelion Pharmaceuticals US, Inc. | 5 | $64 |
| Bayer | 4 | $64 |
| Regeneron Healthcare Solutions, Inc. | 4 | $53 |
| Kiniksa Pharmaceuticals, Ltd. | 2 | $47 |
| Preventice Services, LLC | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $33 |
| Lantheus Medical Imaging, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $14 |
| Regeneron | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $13 |
How this compares
$5,174 in reported general payments places this provider in the 75th percentile of 1,250 cardiovascular disease providers in Pennsylvania.
Other cardiovascular disease in Hermitage
- Hemal GadaWormleysburg$1.8M
- Benjamin KalsmithPgh$1.7M
- Peter KoweyWynnewood$1.5M
- Paul ForfiaPhiladelphia$1.2M
- Quang BuiPhiladelphia$933K
- Rhian DaviesYork$853K
- Sarang MangalmurtiBryn Mawr$728K
- Sabahat BokhariAllentown$578K
- George GabrielPittsburgh$563K
- Rajesh DaveCamp Hill$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.